Novelty Technology Care Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 106

Employees

  • Latest Deal Type
  • PE Growth

  • Financing Rounds
  • 3

  • Investments
  • 4

Novelty Technology Care General Information

Description

Manufacturer of pharmaceutical products, medical devices and food supplements based in Milan, Italy. The company is engaged in the research, development and production of drugs, innovative medical devices and high-quality food supplements that are sold worldwide through licensees and distributors and is involved in the development of products in ophthalmology, gastroenterology and women's health.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Food Products
Corporate Office
  • Via Dei Gracchi, 35
  • 20146 Milan
  • Italy
+39 02 000 0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Novelty Technology Care Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Novelty Technology Care‘s full profile, request access.

Request a free trial

Novelty Technology Care Patents

Novelty Technology Care Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4396192-A1 Compound in the form of particles functionalized with high percentage ionic metal, and its use as an antimicrobial Pending 31-Aug-2022
CA-3228374-A1 Compound in the form of particles functionalized with high percentage ionic metal, and its use as an antimicrobial Pending 31-Aug-2021 000000000
CA-3197797-A1 Ophthalmic composition containing levofloxacin and ketorolac, method for the preparation and use thereof Pending 09-Nov-2020 000000000
AU-2021375352-A1 Ophthalmic composition containing levofloxacin and ketorolac, method for the preparation and use thereof Pending 09-Nov-2020 000000000
EP-4240364-A1 Ophthalmic composition containing levofloxacin and ketorolac, method for the preparation and use thereof Pending 09-Nov-2020 A61P27/02
To view Novelty Technology Care’s complete patent history, request access »

Novelty Technology Care Executive Team (11)

Name Title Board Seat Contact Info
Riccardo Carbucicchio Chief Executive Officer
Luca Loiacono Chief Financial Officer
Silvia Regondi Chief Operating Officer
Alessandro Colombo Chief Scientific Officer
Andrea Boccardi Head of Business Franchise Integration
You’re viewing 5 of 11 executive team members. Get the full list »

Novelty Technology Care Board Members (2)

Name Representing Role Since
00000 000000000 Wise Equity SGR Board Member 000 0000
0000000 000000 Wise Equity SGR Vice Chairman 000 0000
To view Novelty Technology Care’s complete board members history, request access »

Novelty Technology Care Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Novelty Technology Care Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Novelty Technology Care‘s full profile, request access.

Request a free trial

Novelty Technology Care Investments (4)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
NMTech (TiAb and SIAB Based Technology) 12-Jun-2019 000000000 Buildings and Property 00000000
NMTech UK (TiAb and SIAB Technologies) 12-Jun-2019 0000000000 Buildings and Property 00000000
Novartis (Portfolio of Ophthalmic Antibiotics) 31-May-2018 0000000000 Buildings and Property 00000000
PH&T 01-Jan-2016 Buyout/LBO 000.00 Pharmaceuticals
To view Novelty Technology Care’s complete investments history, request access »

Novelty Technology Care FAQs

  • When was Novelty Technology Care founded?

    Novelty Technology Care was founded in 2014.

  • Who is the founder of Novelty Technology Care?

    Nicola Travierso Ph.D is the founder of Novelty Technology Care.

  • Who is the CEO of Novelty Technology Care?

    Riccardo Carbucicchio is the CEO of Novelty Technology Care.

  • Where is Novelty Technology Care headquartered?

    Novelty Technology Care is headquartered in Milan, Italy.

  • What is the size of Novelty Technology Care?

    Novelty Technology Care has 106 total employees.

  • What industry is Novelty Technology Care in?

    Novelty Technology Care’s primary industry is Pharmaceuticals.

  • Is Novelty Technology Care a private or public company?

    Novelty Technology Care is a Private company.

  • What is Novelty Technology Care’s current revenue?

    The current revenue for Novelty Technology Care is 000000.

  • How much funding has Novelty Technology Care raised over time?

    Novelty Technology Care has raised $16.2M.

  • Who are Novelty Technology Care’s investors?

    Unigestion, Medeor Associates, and Wise Equity SGR have invested in Novelty Technology Care.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »